Van Strum & Towne’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.58M | Sell |
40,834
-1,070
| -3% | -$199K | 2.39% | 12 |
|
|
2025
Q1 | $8.78M | Buy |
41,904
+3,012
| +8% | +$631K | 2.95% | 10 |
|
|
2024
Q4 | $6.91M | Buy |
38,892
+7,196
| +23% | +$1.28M | 2.43% | 13 |
|
|
2024
Q3 | $6.26M | Buy |
31,696
+65
| +0.2% | +$12.8K | 2.17% | 15 |
|
|
2024
Q2 | $5.43M | Sell |
31,631
-129
| -0.4% | -$22.1K | 1.97% | 16 |
|
|
2024
Q1 | $5.78M | Sell |
31,760
-240
| -0.8% | -$43.7K | 2.11% | 17 |
|
|
2023
Q4 | $4.96M | Sell |
32,000
-100
| -0.3% | -$15.5K | 1.94% | 16 |
|
|
2023
Q3 | $4.78M | Sell |
32,100
-445
| -1% | -$66.3K | 2.02% | 17 |
|
|
2023
Q2 | $4.38M | Buy |
32,545
+15
| +0% | +$2.02K | 1.81% | 19 |
|
|
2023
Q1 | $5.19M | Sell |
32,530
-175
| -0.5% | -$27.9K | 2.22% | 14 |
|
|
2022
Q4 | $5.29M | Sell |
32,705
-115
| -0.4% | -$18.6K | 2.28% | 13 |
|
|
2022
Q3 | $4.41M | Sell |
32,820
-339
| -1% | -$45.5K | 2.03% | 16 |
|
|
2022
Q2 | $5.08M | Buy |
33,159
+74
| +0.2% | +$11.3K | 2.16% | 14 |
|
|
2022
Q1 | $5.36M | Buy |
33,085
+755
| +2% | +$122K | 2.01% | 17 |
|
|
2021
Q4 | $4.38M | Buy |
32,330
+930
| +3% | +$126K | 1.59% | 20 |
|
|
2021
Q3 | $3.39M | Buy |
31,400
+550
| +2% | +$59.3K | 1.33% | 23 |
|
|
2021
Q2 | $3.48M | Sell |
30,850
-230
| -0.7% | -$25.9K | 1.66% | 20 |
|
|
2021
Q1 | $3.36M | Buy |
31,080
+1,595
| +5% | +$173K | 1.7% | 19 |
|
|
2020
Q4 | $3.16M | Buy |
29,485
+600
| +2% | +$64.3K | 1.76% | 18 |
|
|
2020
Q3 | $2.53M | Buy |
28,885
+195
| +0.7% | +$17.1K | 1.64% | 17 |
|
|
2020
Q2 | $2.82M | Buy |
28,690
+25,560
| +817% | +$2.51M | 1.96% | 17 |
|
|
2020
Q1 | $238K | Buy |
3,130
+234
| +8% | +$17.8K | 0.19% | 59 |
|
|
2019
Q4 | $256K | Hold |
2,896
| – | – | 0.16% | 63 |
|
|
2019
Q3 | $219K | Buy |
+2,896
| New | +$219K | 0.14% | 70 |
|